Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
Crossject (ISIN: FR0011716265; Euronext Growth: ALCJ), a specialty pharma company developing medicines harnessing its unique, award-winning needle-free ...
InfuSystem Set For Strong Year
InfuSystem Holdings projects impressive growth with strong agreements. Find out why INFU stock is expected to reach ...